| P2093 | author name string | Péter Hegyi | |
| | Nelli Farkas | |
| | Emese Mezősi | |
| | Patrícia Sarlós | |
| | Katalin Márta | |
| | Zsolt Szakács | |
| | Adrienn Erős | |
| | Alexandra Soós | |
| | Bálint Erőss | |
| | Kata Szemes | |
| P2860 | cites work | Immunosuppressive effects of cyclosporin A on cloned T cells | Q69986357 |
| | Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis | Q83567286 |
| | Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis | Q84341621 |
| | Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks | Q87420118 |
| | Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis | Q89260034 |
| | Outcome of a conservative approach in severe ulcerative colitis | Q44769293 |
| | Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis | Q45734256 |
| | Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. | Q46130626 |
| | Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. | Q46531976 |
| | Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. | Q48095368 |
| | Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis | Q48161573 |
| | Acute severe ulcerative colitis: latest evidence and therapeutic implications | Q49232336 |
| | Cortisone in ulcerative colitis; preliminary report on a therapeutic trial | Q50417466 |
| | Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. | Q50891880 |
| | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 |
| | Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis. | Q53657609 |
| | Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. | Q54563945 |
| | Preliminary report: cyclosporin in treatment of severe active ulcerative colitis | Q68091416 |
| | Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study | Q68206432 |
| | Intensive intravenous treatment of ulcerative colitis | Q69964499 |
| | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 |
| | Meta-analysis in clinical trials | Q27860779 |
| | Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit | Q30664895 |
| | Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis | Q33596959 |
| | Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 |
| | Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves | Q34148380 |
| | Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study | Q34187731 |
| | Predicting outcome in severe ulcerative colitis | Q34409849 |
| | Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study. | Q36037115 |
| | Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). | Q36058400 |
| | The pattern and outcome of acute severe colitis | Q37814560 |
| | Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. | Q37957998 |
| | Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. | Q37964767 |
| | Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article | Q38056526 |
| | Use of antioxidants to prevent cyclosporine a toxicity | Q38166348 |
| | Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study. | Q38694769 |
| | Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids | Q38726448 |
| | Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients | Q40051749 |
| | Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis | Q43553836 |
| | The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients | Q44033640 |
| | Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study | Q44319021 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 338 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis | |
| P478 | volume | 6 | |